Jan Bergervoet

Jan Bergervoet

Advisory Board Member

Mr. Bergervoet joined Wageningen University & Research after his study and worked in the fields of seed health and development, flow cytometry and proteomics. From 2000 onwards he started working on bead based detection of plant pathogens and in 2011 he joined Prime Diagnostics a commercial project within Wageningen University & Research focusing on production and world wide sales of reagents for the detection of plant pathogens. Since 2016 he has the team lead on new product development, technology transfer of reagent production and method development for the detection of plant pathogens.

Jan Bergervoet

Arnout Gerritsen

Arnout Gerritsen

Advisory Board Member

Mr. A. Gerritsen (Sr Director, Global Head Bioanalytical Science at Genmab) obtained his BSc in Zoology & Histology at the University of applied science, Delft, The Netherlands. Since 1990 he has been involved in the field of immunology and antibodies. In 1997 he joined Medarex Europe, a subsidiary of Medarex Inc., starting up new laboratories for therapeutic antibody development. In 1999, he joined Genmab, where he held several managerial positions in the Discovery and Development of therapeutic antibodies. Currently, he holds the position of Sr Director, Global Head of Bioanalytical Science at Genmab. Throughout his career, he acquired a broad experience with assay technologies, including label-free sensing technologies to support antibody discovery and development. During 2012-2016 he served as a member of the Scientific Advisory Board of Pall Biopharmaceuticals.

Guy Dewil

Guy Dewil, MD

Chief Executive Officer

Guy Dewil is an experienced senior leader with a demonstrated history of working in global pharmaceuticals and CROs, including Catalent, Syneos Health (Previously INC Research/inVentiv Health) and GE Healthcare. His unique combination of a medical background with broad scientific interests, give him the skillset to push innovation in Life Sciences and Healthcare forward. He counts over 25 years in leading and managerial positions, that provided him with the expertise of leading dynamic teams and growing revenues and profits.

Dr. Michael Schraeml

Dr. Michael Schraeml

Board Member

Dr. Schraeml obtained his PhD in Biotechnology at the Martin Luther Universität, Halle-Wittenberg, after which he joined Scil Proteins GmbH in the position of Head of Affilin technology (development of artificial binding proteins). In 2007, he joined Roche Diagnostics GmbH, Penzberg, Germany, where started as Team Lead Biointeraction Analysis and currently holds the position of Director Antigen Design & Protein Expression Technologies. Dr. Schreaml has a vast experience in all facets of real time interaction measurement assays and label-free biosensing technologies, an area which he has been involved in since 1999.

 

Ruben van Harmelen

Ruben van Harmelen, MSc

Product Application Specialist

Ruben van Harmelen obtained his masters in Biomedical Engineering at the Univeristy of Groningen. As Product Application Specialist, he is able to combine his in-depth knowledge of biology, engineering and product development and manages the assembly and deployability of Delta Diagnostics’ instruments. Ruben also delivers technical support to our customers.